• Call +1.858.633.0165 or Fax +1.858.633.0166 or Contact Us

PF-04802367 Inhibitor

For Research Use Only. Not for use in diagnostic procedures. Catalog #: MBS5786457

PF-04802367 is a highly selective GSK-3 inhibitor with an IC50 of 2.1nM based on a recombinant Human GSK-3beta enzyme assay and 1.1nM based on ADP-Glo assay. It shows desirable central nervous system (CNS) properties and potency. It is equally effective at… More details

Product Documentation
PDF
Sample Manual Insert View PDF
PDF
Testing Data View PDF
PDF
Certificate of Analysis (COA) View PDF
PDF
QC Report View PDF
PDF
Material Safety Data Sheet View PDF
PDF
Technical Datasheet View PDF
PDF
Protocol View PDF

Product Overview

Online Datasheet in PDF
Product Name
PF-04802367, Inhibitor
Full Product Name
PF-04802367
Product Gene Name
Purity/Purification
98%
Preparation and Storage
Powder: -2 degree C for 3 years
In solvent: -80 degree C for 2 years
Molecular Weight
361.78
SMILES
COc(ccc(-c1c(C(NCCCn2ncnc2)=O)nco1)c1)c1Cl
Formula
C16H16ClN5O3
CAS Number
1962178-27-3
Target
GSK-3
GSK-3alpha: 10nM (IC50), GSK-3beta: 9nM (IC50)
Solubility
DMSO: 100mg/mL (276.41 mM),
Need ultrasonic
(<1mg/mL refers to the product slightly soluble or insoluble)
In_vitro
PF-04802367 (PF-367) a potent GSK-3 inhibitor with exceptional kinome selectivity that modulates phosphorylated tau levels in vivo. Inhibition of phosphorylation of tau in brain by PF-367 (A single subcutaneous of 1, 3.2, 10, 32 or 50mg/kg) is dose-dependent[1]. PF-04802367 (PF-367), a potent type-I dual GSK-3alpha/beta inhibitor, showing promising absorption; distribution, metabolism and elimination (ADME) properties combined with robust CNS/peripheral p-Tau and muscle phosphorylated glycogen synthase (pGS) inhibition in vivo[2].

Structure of PF-04802367, inhibitor

PF-04802367, CAS 1962178-27-3
PF-04802367 Inhibitor – Cat# MBS5786457

Structure of PF-04802367, inhibitor

PF-04802367, CAS 1962178-27-3
PF-04802367 Inhibitor, Structure – Cat# MBS5786457

Other Notes

Small volumes of PF-04802367, inhibitor vial(s) may occasionally become entrapped in the seal of the product vial during shipment and storage. If necessary, briefly centrifuge the vial on a tabletop centrifuge to dislodge any liquid in the container`s cap. Certain products may require to ship with dry ice and additional dry ice fee may apply.

Searchable Terms for PF-04802367 purchase

MBS5786457 is an inhibitor targeting PF-04802367.
Request a Quote

Please fill out the form below and our representative will get back to you shortly.

MBS000000
Contact Us

Please fill out the form below and our representative will get back to you shortly.

MBS000000